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ﻝﺎﻤﺘﺣﺇﺐﺒﺴﺑﻱﻮﻴﺤﻟﺍﺐﻄﻟﺍﺽﺍﺮﻏﻷﺓﺪﻳﺍﺰﺘﻣﺓﺭﻮﺼﺑﺔﻳﻮﻧﺎﻨﻟﺍﺔﻀﻔﻟﺍﻡﺪﺨﺘﺴﺗ
ﺔﻳﻮﻠﺨﻟﺍﺔﻤﻈﻧﻷﺍﻰﻠﻋﺎﻫﺮﻴﺛﺄﺗﻥﺈﻓﻚﻟﺫﻊﻣﻭ.ﺕﺎﺑﻭﺮﻜﻴﻤﻠﻟﺎﻬﺗﺩﺎﻀﻣﺔﻴﺻﺎﺧﺩﻮﺟﻭ
ﻩﺬﻫﺭﺎﺛﺁﻢﻴﻴﻘﺘﺑﺍﺬﻫﺎﻨﺜﺤﺑﻲﻓﺎﻨﻤﻗ.ﺔﻴﺜﺤﺒﻟﺍﺕﺎﺳﺍﺭﺪﻟﺍﻦﻣﻞﻴﻠﻗﺩﺪﻋﻲﻓﻻﺇﺮﻛﺬﻳﻢﻟ
ﻦﻣﺕﺎﻋﻮﻤﺠﻣ6ﻰﻠﻋﺓﺪﺴﻛﻸﻟﺓﺩﺎﻀﻤﻟﺍﻥﺍﺮﺌﻔﻟﺍﺔﻟﺎﺣﻰﻠﻋﺔﻳﻮﻧﺎﻨﻟﺍﺕﺎﻤﻴﺴﺠﻟﺍ
ﻭ001ﻢﻬﺋﺎﻄﻋﺍﻢﺗﻭ.ﻥﺍﺮﺌﻓﺲﻤﺧﻦﻣﻥﻮﻜﺘﺗﺔﻋﻮﻤﺠﻣﻞﻛﺭﺎﺘﺴﻳﻭﻥﺍﺮﺌﻔﻟﺍﺭﻮﻛﺫ
ﻦﻋﺓﺭﻭﺭﺎﻗﻝﻼﺧﻦﻣﺔﻳﻮﻧﺎﻨﻟﺍﺔﻀﻔﻟﺍﻦﻣﺎﻴﻣﻮﻳﻡﺍﺮﻏﻮﻠﻴﻛ/ﻎﻠﻣ0005ﻭﺃ0001
12ﺓﺪﻤﻟﻎﻛ/ﻎﻠﻣ0005ﺓﺪﺣﺍﻭﺔﻋﻮﻤﺠﻣﺖﻘﻠﺗﻭ،ﻡﺎﻳﺃ41ﻭﺃ7ﺓﺪﻤﻟﻢﻔﻟﺍﻖﻳﺮﻃ
ﺔﻋﺎﺳ42ﺪﻌﺑﺕﺎﻧﺍﻮﻴﺤﻟﺍﺢﺑﺫﻢﺗ.ﻂﻘﻓﺮﻄﻘﻤﻟﺍﺀﺎﻤﻟﺍﺔﺒﻗﺍﺮﻣﺔﻋﻮﻤﺠﻣﺖﻘﻠﺗﻭ،ﺎﻣﻮﻳ
ﺕﺮﺛﺃ.ﺔﺳﺍﺭﺪﻠﻟﻥﺍﺮﺌﻔﻟﺍﺔﺠﺴﻧﺃﻭﻞﺼﻣﻦﻣﺕﺎﻨﻴﻋﺕﺬﺧﺃﻭ،ﺝﻼﻌﻟﺍﻢﻬﻴﻘﻠﺗﺔﻳﺎﻬﻧﻦﻣ
ﺕﺎﻤﻳﺰﻧﻹﺍﺾﻌﺑﺕﺍﺰﻴﻛﺮﺗﺓﺩﺎﻳﺯﻰﻠﻋ(50.0 < P)ﺎﻳﻮﻨﻌﻣﺔﻳﻮﻧﺎﻨﻟﺍﺔﻀﻔﻟﺍ
ﻥﻮﻫﺪﻟﺍﺓﺪﺴﻛﺃﺐﺒﺴﺗﺪﻗﺔﻀﻔﻟﺍﺕﺎﺌﻳﺰﺟﻥﺃﻰﻟﺇﺮﻴﺸﺗﺞﺋﺎﺘﻨﻟﺍﻩﺬﻫﻭ.ﺾﻌﺒﻟﺍﺾﻔﺧﻭ
.ﻥﺍﺮﺌﻔﻠﻟﺔﻳﻮﻠﺨﻟﺍﺔﻤﻈﻧﻷﺍﺓﺪﺴﻛﻸﻟﺓﺩﺎﻀﻤﻟﺍﻊﺿﻮﻟﺍﺮﻴﻴﻐﺗﻭ
ﺔﻴﻧﺪﻌﻣﺕﺎﻤﻴﺴﺟ;ﻥﻮﻫﺪﻟﺍﺪﺴﻛﺄﺗ;ﺓﺪﺴﻛﻷﺍﺕﺍﺩﺎﻀﻤﻠﻟﺓﺩﺎﻀﻤﻟﺍ:ﺔﻴﺣﺎﺘﻔﻤﻟﺍﺕﺎﻤﻠﻜﻟﺍ
ﺔﻴﻤﺴﻟﺍ;ﻱﻮﻧﺎﻨﻟﺍﺐﻃﺮﻐﺼﻟﺍﺔﻴﻫﺎﻨﺘﻣ
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http://dx.doi.org/10.1016/j.jtumed.2014.03.002groups of five male Wistar rats. Six groups of rats were
given 100, 1000 or 5000 mg/kg daily through an oral can-
nula for 7 or 14 days, one group received 5000mg/kg for 21
days, and a control group received distilled water. The
animals were sacrificed 24 h after the end of treatment, and
serum and tissue homogenates were prepared. Silver
nanoparticles significantly (p < 0.05) increased the con-
centrations of malondialdehyde and superoxide dismutase
but decreased the levels of reduced glutathione, glutathione
S-transferase and catalase. These results indicate that silver
nanoparticles may cause lipid peroxidation and alter anti-
oxidant status in a manner that may cause oxidative stress.
Keywords: Antioxidant; Lipid peroxidation; Metal nano-
particle; Nanomedicine; Toxicity
 2014 Taibah University. Production and hosting by
Elsevier Ltd. All rights reserved.Introduction
Nanoparticles are employed in constructing micro and
nano devices used in electronics, in applications including
adhesion, lubrication, stabilization and controlled floccu-
lation of colloidal dispersions and in several other appli-
cations, including cellular delivery and imaging.1,2 Owing
to their small size and large ratio of surface area to
volume, nanoparticles can interact with biomolecules and
penetrate cell and nuclear membranes, causing indirect
oxidative damage to DNA, inducing an inflammatory
response and oxidative stress.3 Potential risks may
therefore be associated with their use. For instance,
nanoparticles have been implicated in cellular injury4
because of their ability to produce reactive oxygen
species directly or indirectly.5
Figure 1: UV/Vis spectrum at 430 nm and transmission electron
microscopy characterization of silver nanoparticles.
O.S. Adeyemi and T.O. Faniyan 183Silver nanoparticles have the broadest commercial ap-
plications of all nanomaterials because of their antibacterial
properties.3,6,7 Although they can act as free radical
scavengers or reducing agents and quenchers of singlet
oxygen formation,8 they can also interact with cellular
proteins and enzymes, with toxic effects.9e11 However,
there are no comprehensive safety or toxicity profiles of
silver nanoparticles. The aim of this study was to
investigate the effects of repeated administration of these
nanoparticles on the antioxidant status of Wistar rats.
Materials and Methods
Preparation of nanoparticles
Silver nanoparticles were synthesized according to estab-
lished protocols, with little modification. First, 100 mmol/L
silver nitratewere added to a 1%(w/v) tannic acid solution (pH
adjusted to 8 by addition of 150mmol/L potassium carbonate)
of polyvinylpyrrolidone with stirring.12 A pale yellow colour
revealed the presence of silver nanoparticles. The particles
were filtered through a 0.22-mm filter and characterized by
ultravioletevisible (UV/Vis) spectrophotometry (Biotek
Epoch, USA), inductively coupled plasma optical emission
spectrometry (Cambridge, United Kingdom) and
transmission electron microscopy (TEM, Brno, Czech
Republic). All reagents were of analytical grade and prepared
in distilled water unless otherwise stated.
Animals and treatments
Male Wistar rats weighing 190e220 g were obtained from
the University of Ibadan, Ibadan, Nigeria, and housed in awell-ventilated, hygienic experimental animal house for 1
week to acclimatize them before the start of the experiment.
They were fed a constant weight of commercial rat pellets
and clean water.
Forty rats were grouped randomly into eight groups of
five animals. One served as the control group and received
distilled water. Three groups were treated with 100, 1000 or
5000 mg/kg silver nanoparticles for 7 days, and three
further groups received the same concentrations for 14
days, while the eighth group received 5000 mg/kg for 21
days.
The doses were determined on the basis of a recent study
in which the LD50 for silver nanoparticles was reported to be
of >5000 mg/kg.13 The nanoparticles were administered
daily to the rats by means of a cannula. The rats were
weighed daily to determine the effects of the nanoparticles
on their weight and were sacrificed 24 h after cessation of
treatments. The study was carried out in accordance with
Institutional guidelines on the handling of animals as
approved for scientific research.Necroscopy
Animals were fasted overnight and sacrificed under slight
chloroform anaesthesia 24 h after the last dose of nano-
particles. Blood samples were obtained by cardiac puncture,
transferred to clean test bottles and centrifuged at 4000  g
for 5 min to obtain serum. The heart, liver and kidneys of
each animal were removed and weighed immediately, then
homogenized in ice-cold 0.25 mol/L sucrose (1:5 w/v) in a
Teflon homogeniser (SigmaeAldrich Chemie GmbH,
Munich, Germany). The homogenates were then centrifuged
at 4000  g for 5 min (Heraeus Labofuge 300, Thermo Sci-
entific, Hampshire, United Kingdom) to remove unbroken
particulates. Tissue homogenates and serum were kept
frozen until analysis.Biochemical assays
Extracts of serum, kidney, liver and heart were analysed
in a UV/Vis spectrophotometer (Shimadzu, Kyoto, Japan)
for reduced glutathione (GSH), catalase, superoxide dis-
mutase, malondialdehyde and glutathione S-transferase
(GST). GSH was determined by the protocol described by
Ellman14 as previously reported,15 catalase by the method
described by Singha,16 superoxide dismutase by the method
described by Misra and Fridovich,17 as previously reported
by Adeyemi et al.,15 malondialdehyde by the protocol
described by Niehaus and Samuelson18 and GST by the
method described by Habig et al.19Data analysis
Data were analysed on Graphpad Prism 3 (GraphPad
Software Inc., San Diego, California) with one-way anal-
ysis of variance (ANOVA). Post-hoc tests were conducted
with the Tukey test. Data are reported as
means  standard error of mean. Values of p <0.05 were
considered significant.
Table 1: Effects of silver nanoparticles on levels of reduced glutathione (GSH), malondialdehyde (MDA), superoxide dismuatse (SOD),
catalase (CAT) and glutathione ese transferase (GST) in rat serum, after daily oral exposure.
GSH MDA SOD CAT GST
7 days
Control (0 mg/kg) 0.14  0.01 0.05  0.00 6.06  0.39 0.45  0.02 3.73  0.14
100 mg/kg 0.15  0.01 0.17  0.00* 8.23  0.07* 0.13  0.03* 0.13  0.01*
1000 mg/kg 0.16  0.00 0.19  0.01* 12. 46  0.34* 0.18  0.02* 0.22  0.00*
5000 mg/kg 0.16  0.02 0.29  0.00* 12.56  0.21* 0.25  0.02* 0.65  0.02*
14 days
Control (0 mg/kg) 0.14  0.01 0.05  0.00 6.06  0.39 0.45  0.02 3.73  0.14
100 mg/kg 0.12  0.00 0.14  0.03* 8.67  0.67* 0.13  0.02* 0.44  0.00*
1000 mg/kg 0.01  0.00*a 0.29  0.00* 7.00  0.28# 0.47  0.03 1.23  0.11*
5000 mg/kg 0.01  0.00a 0.30  0.00* 9.10  0.23* 0.26  0.02* 0.38  0.20*
21 days
Control (0 mg/kg) 0.14  0.01 0.05  0.00 6.06  0.39 0.45  0.02 3.73  0.14
5000 mg/kg 0.01  0.00a 1.00  0.00*b 10.06  0.27* 0.36  0.02b 0.34  0.01*
Values are mean SEM (n¼ 5). Values with different superscripts in the same column are significantly different at p< 0.05. * is significant
relative to control group; a is significant relative to groups receiving 100 mg/kg; b is significant relative to groups receiving 100 and
1000 mg/kg.
Nanoparticles promote lipid peroxidation184Results
The aqueous solution of silver nanoparticles had a char-
acteristic brownish-yellow colour (Figure 1). TEM images
showed that the diameter of the nanoparticles was 8e20 nm.
Daily administration of silver nanoparticles to rats
significantly decreased the levels of GSH relative to the
control group in serum (), liver, kidney and heart, while it
significantly increased the levels of malondialdehyde
(Tables 1e4), depending on the concentration and duration
of treatment. Silver nanoparticles inconsistently increased
the serum level of superoxide dismutase relative to the
control group (Tables 1e4) but significantly increased the
levels in liver, kidney and heart. Inconsistent alterations
were observed in the levels of catalase relative to controls
(Tables 1e4). The nanoparticles decreased the serum and
tissue levels of GST at all concentrations (Tables 1e4).Table 2: Effects of silver nanoparticles on levels of reduced glutathione
catalase (CAT) and glutathione ese transferase (GST) in rat liver,
GSH MDA
7 days
Control (0 mg/kg) 0.16  0.00 0.03  0.00
100 mg/kg 0.07  0.00* 0.08  0.00*
1000 mg/kg 0.07  0.00* 0.11  0.01*
5000 mg/kg 0.06  0.00* 0.13  0.01*
14 days
Control (0 mg/kg) 0.16  0.00 0.03  0.00
100 mg/kg 0.04  0.00* 0.08  0.00*
1000 mg/kg 0.04  0.00* 0.20  0.00*
5000 mg/kg 0.06  0.00* 0.14  0.02*
21 days
Control (0 mg/kg) 0.16  0.00 0.03  0.00
5000 mg/kg 0.01  0.00* 0.33  0.01*
Values are mean SEM (n¼ 5). Values with different superscripts in th
relative to control group; a is significant relative to groups receiving 100
receiving 100 and 1000 mg/kg.Discussion
Exposure to silver nanoparticles significantly decreased
the levels of GSH in rat serum and tissues. GSH is an anti-
oxidant that can quench free radicals or serve as a substrate
for other antioxidant enzymes, such as glutathione peroxi-
dase and glutathione reductase. The decreased levels of GSH
after exposure to silver nanoparticles may be due to com-
plexing of silver nanoparticles with thiol groups20,21 or to
increasing use of GSH to downplay the effect of free
radicals after exposure to of the nanoparticles.22 These
nanoparticles have a strong affinity for thiol groups20 and
may therefore predispose to a decrease in GSH content,
thereby leading to the formation of complexes between
radical species and cellular proteins or other biomolecules.
The levels of malondialdehyde were elevated in serum and
tissues after exposure to silver nanoparticles, which may(GSH), malondialdehyde (MDA), superoxide dismuatse (SOD),
after daily oral exposure.
SOD CAT GST
2.21  0.01 1.41  0.03 3.17  0.11
5. 85  0.20* 1.88  0.10* 2.19  0.02*
4. 92  0.25*a 1.87  0.08* 0.46  0.00*
5.79  0.17* 1.13  0.10 0.67  0.02*b
2.21  0.01 1.41  0.03 3.17  0.11
3.27  0.09* 0.42  0.02* 2.28  0.07*
3.18  0.11*a 0.38  0.01* 2.23  0.11*
3.77  0.10* 0.62  0.05*b 1.15  0.03*b
2.21  0.01 1.41  0.03 3.17  0.11
6.10  0.40* 0.51  0.03* 0.93  0.10*b
e same column are significantly different at p< 0.05. * is significant
and 5000 mg/kg for 7 and 21 days; b is significant relative to groups
Table 3: Effects of silver nanoparticles on levels of reduced glutathione (GSH), malondialdehyde (MDA), superoxide dismuatse (SOD),
catalase (CAT) and glutathione ese transferase (GST) in rat kidney, after daily oral exposure.
GSH MDA SOD CAT GST
7 days
Control (0 mg/kg) 0.16  0.01* 0.06  0.03 5.85  0.45 0.53  0.06 1.69  0.05
100 mg/kg 0.04  0.00* 0.07  0.02 9.77  0.44* 0.27  0.05* 0.69  0.06*
1000 mg/kg 0.06  0.00* 0.10  0.04* 17.38  0.79* 0.11  0.01* 0.55  0.03*
5000 mg/kg 0.07  0.01* 0.10  0.00* 14.68  1.12* 0.28  0.02* 0.27  0.05*
14 days
Control (0 mg/kg) 0.16  0.01 0.06  0.03 5.85  0.45 0.53  0.06 1.69  0.05
100 mg/kg 0.01  0.00* 0.21  0.02* 10.65  0.33* 0.31  0.06 0.66  0.08*
1000 mg/kg 0.04  0.00* 0.10  0.04* 6.73  0.06b 0.40  0.04 0.93  0.06*
5000 mg/kg 0.06  0.01* 0.10  0.01* 17.71  0.84* 0.31  0.06 0.82  0.05*
21 days
Control (0 mg/kg) 0.16  0.01 0.06  0.03 5.85  0.45 0.53  0.06 1.69  0.05
5000 mg/kg 0.07  0.00* 0.26  0.10*a 14.74  0.29* 0.34  0.05 0.91  0.06*
Values are mean SEM (n¼ 5). Values with different superscripts in the same column are significantly different at p< 0.05. * is significant
relative to control group; a is significant relative to groups receiving 100 and 1000 mg/kg; b is significant relative to groups receiving 100 and
5000 mg/kg.
Table 4: Effects of silver nanoparticles on levels of reduced glutathione (GSH), malondialdehyde (MDA), superoxide dismuatse (SOD),
catalase (CAT) and glutathione ese transferase (GST) in rat heart, after daily oral exposure.
GSH MDA SOD CAT GST
7 days
Control (0 mg/kg) 0.19  0.001 0.04  0.00 4.72  0.36 1.10  0.02 2.23  0.04
100 mg/kg 0.17  0.003a 0.06  0.00 7.17  0.50* 0.87  0.05 0.23  0.01*
1000 mg/kg 0.01  0.001* 0.06  0.00 8.80  0.50* 0.83  0.05 1.06  0.04*
5000 mg/kg 0.01  0.001* 0.07  0.00 10.96  0.32* 0.81  0.07 0.81  0.01*
14 days
Control (0 mg/kg) 0.19  0.001 0.04  0.00 4.72  0.36 1.10  0.02 2.23  0.04
100 mg/kg 0.10  0.002* 0.89  0.01* 5.39  0.07 0.78  0.03 0.10  0.00*
1000 mg/kg 0.13  0.002 0.74  0.01* 10.90  0.28* 0.47  0.03* 0.15  0.00*
5000 mg/kg 0.10  0.001* 0.84  0.01* 6.99  0.32 0.26  0.03* 0.13  0.01*
21 days
Control (0 mg/kg) 0.19  0.001 0.04  0.00 4.72  0.36 1.10  0.02 2.23  0.04
5000 mg/kg 0.01  0.001* 1.28  0.02*U 8.76  0.43* 0.36  0.02* 0.34  0.01*
Values are mean SEM (n¼ 5). Values with different superscripts in the same column are significantly different at p< 0.05. * is significant
relative to control group; a is significant relative to groups receiving 1000 and 5000 mg/kg; U is significant relative to groups receiving 100
and 1000 mg/kg.
O.S. Adeyemi and T.O. Faniyan 185indicate oxidative stress. A similar result was found previ-
ously in zebrafish.15 We also found that superoxide
dismutase levels were inconsistently elevated after exposure
to the nanoparticles. This is an inducible enzyme, and
elevated levels may indicate the presence of reactive
species; a previous report linked elevated superoxide
dismutase levels to the presence of oxidative stress.15
Catalase levels were inconsistently altered after exposure,
as observed previously in broilers.23 Conversely, silver
nanoparticles caused inconsistent reductions in the levels of
GST in serum and tissues, perhaps because the
nanoparticles have an affinity for thiol groups.20,21 The
alterations in the levels of these enzymes may represent an
adaptive mechanism to offset the stress of exposure.
Our findings are not completely in accordance with those
of an earlier report,13 in which the LD50 of silver
nanoparticles in mice was >5000 mg/kg. Other studies
showed that exposure of rats to silver nanoparticles canalter biochemical processes24,25 independently of dose,26
and several studies have demonstrated that these
nanoparticles can sequester and accumulate in vital organs,
including the kidney, liver, testes and brain.24e26 This may
explain why the biochemical alterations caused by silver
nanoparticles became more pronounced with longer
exposure and indicates that caution should be exercised in
their use for biomedical purposes.Conclusions
Silver nanoparticles caused lipid peroxidation and
altered the levels of GSH, superoxide dismutase and cata-
lase in Wistar rats. Further in-depth studies of the in-
teractions between metal nanoparticles and cellular
materials are required to increase our understanding of their
mechanisms of action.
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